WGCA
ABBV icon

Wolf Group Capital Advisors’s AbbVie ABBV Stock Holding History

Wolf Group Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$251K Buy
+1,198
New +$233K 0.08% 144
2023
Q2 		– Sell
-11,795
Closed -$1.88M – 105
2023
Q1 		$1.88M Sell
11,795
-1,302
-10% -$199K 0.93% 36
2022
Q4 		$2.12M Sell
13,097
-1,544
-11% -$237K 1% 32
2022
Q3 		$1.97M Sell
14,641
-20
-0.1% -$2.87K 1.08% 30
2022
Q2 		$2.25M Sell
14,661
-1,190
-8% -$182K 1.17% 28
2022
Q1 		$2.57M Sell
15,851
-33,653
-68% -$4.89M 1.31% 23
2021
Q4 		$6.7M Buy
49,504
+32,825
+197% +$3.88M 1.1% 29
2021
Q3 		$1.8M Sell
16,679
-325
-2% -$37.1K 0.98% 38
2021
Q2 		$1.92M Buy
17,004
+736
+5% +$82.9K 1.03% 36
2021
Q1 		$1.76M Buy
16,268
+812
+5% +$86.9K 1.01% 41
2020
Q4 		$1.66M Buy
15,456
+188
+1% +$18.1K 1.02% 39
2020
Q3 		$1.34M Sell
15,268
-77
-0.5% -$7.25K 0.93% 42
2020
Q2 		$1.51M Buy
15,345
+212
+1% +$18.7K 1.12% 33
2020
Q1 		$1.15M Buy
15,133
+22
+0.1% +$1.87K 0.96% 39
2019
Q4 		$1.34M Sell
15,111
-113
-0.7% -$9.38K 0.88% 44
2019
Q3 		$1.15M Buy
15,224
+542
+4% +$37.2K 0.79% 43
2019
Q2 		$1.07M Sell
14,682
-1,085
-7% -$85.3K 0.74% 43
2019
Q1 		$1.27M Sell
15,767
-98
-0.6% -$8.02K 0.87% 38
2018
Q4 		$1.46M Buy
+15,865
New +$1.4M 1.09% 33
2018
Q2 		– Hold
0
– – – 41
2018
Q1 		– Sell
-12,761
Closed -$1.23M – 101
2017
Q4 		$1.23M Buy
12,761
+1,653
+15% +$156K 0.77% 57
2017
Q3 		$1.01M Buy
+11,108
New +$846K 0.7% 60
2016
Q4 		– Sell
-19,471
Closed -$1.23M – 102
2016
Q3 		$1.23M Sell
19,471
-679
-3% -$44K 0.86% 50
2016
Q2 		$1.25M Buy
20,150
+12,538
+165% +$764K 0.92% 48
2016
Q1 		$435K Buy
+7,612
New +$424K 0.33% 70

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wolf Group Capital Advisors's ABBV Position: Q1 2025 in Review

Wolf Group Capital Advisors opened a new position in AbbVie (ABBV) in Q1 2025: 1,198 shares worth $251K. The stake represents 0.08% of the portfolio and ranks #144 among its holdings. This is a return to the name: Wolf Group Capital Advisors previously reported a position in ABBV as recently as Q1 2023.

Wolf Group Capital Advisors first reported a position in ABBV in Q1 2016 and has held it in 24 quarters since. The position peaked at $6.7M in Q4 2021. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Wolf Group Capital Advisors held 1,198 shares of AbbVie worth $251K as of Q1 2025.
  • AbbVie was a new Wolf Group Capital Advisors position in Q1 2025.
  • AbbVie made up 0.08% of Wolf Group Capital Advisors's portfolio in Q1 2025, its #144 holding.
  • Wolf Group Capital Advisors first reported a position in AbbVie in Q1 2016 and has held it in 24 quarters since.
  • Wolf Group Capital Advisors's AbbVie position peaked at $6.7M in Q4 2021.
  • 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Wolf Group Capital Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.